跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VERZENIO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
VERZENIO
Authorized
STANDARD
VERZENIO
eli lilly canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
10609977e64beb33
Company
eli lilly canada inc
Type
Standard
Approval Details
Approval Id
10609977e64beb33
Drug Approval Canada Name
VERZENIO
Product Name
VERZENIO
Status
Marketed
Status Date
2019-07-03
Original Market Date
2019-07-03
Din
02487098
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01EF03 ABEMACICLIB
Atc Name
l 01 ef 03
Aig Number
0161330001
Company Name
eli lilly canada inc
Company Address
SUITE 900, Exchange Tower, 130 King Street West, Toronto, Ontario, Canada, M5X 1B1
Active Ingredients
ABEMACICLIB
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
10609977e64beb33
Type
Standard
Back to Health Canada Approvals